Latest Ceryvyn Therapeutics (ASX:CYV) News

Ceryvyn Therapeutics (ASX:CYV) marked its return to the ASX with progress in its rare lung disease program, filing a new US patent and assembling a high-profile Scientific Advisory Board to guide its CYV-101 development.